Flickering light stimulation of retinal photoreceptors induces retinal vessel dilation in humans. In the present study the effect of high blood glucose levels on this neuro-vascular mechanism was investigated in 12 healthy young male subjects. Blood glucose levels were consecutively increased during 30 min to 100, 200 and 300 mg/dl and kept at the respective level for the following 30 min using hyperglycemic insulin clamps. Eight Hertz flickering light was applied to the fundus at the end of each glucose plateau during continuous retinal vessel diameter measurements with the Zeiss retinal vessel analyser (RVA). During normoglycemia (100 mg/dl) flickering light induced a significant vasodilation of retinal arteries (+2.8 AE 0.4%, p < 0:0001) and veins (+2.6 AE 0.4%, p < 0:0001). At 300 mg/dl blood glucose the flicker response in retinal veins was significantly decreased by 55% (p ¼ 0:015 versus 100 mg/dl). The modified RVA employed in the present study provides high sensitivity and is capable of studying flicker-induced retinal vasodilation. Using this technique the present study confirms that flickering light stimulation of the human retina induces vasodilation in retinal vessels in healthy subjects. In addition, our data indicate that the retinal vessel response to flickering light stimulation is significantly reduced during hyperglycemia in humans. The relevance of this finding for diabetes-related eye disease remains to be shown.
Introduction
Previous studies have demonstrated that increases in retinal neuronal activity are associated with increases in retinal metabolism and blood flow (Buerk, Riva, & Cranstoun, 1995; Formaz, Riva, & Geiser, 1979; Kiryu, Asrani, Shahidi, Mori, & Zeimer, 1995; Riva, Harino, Shonat, & Petrig, 1991; Scheiner, Riva, Kazahaya, & Petrig, 1994; Van Toi & Riva, 1995) . Flickering light stimulation of the human fundus increases the activity of retinal ganglion cells, causing a release of local vasodilating factors. The subsequent increase in retinal and optic nerve head blood flow has been measured in cats, primates and humans with different methods (Buerk et al., 1995; Kiryu et al., 1995; Riva, Cranstoun, Mann, & Barnes, 1994; Riva, Cranstoun, & Petrig, 1996; Riva et al., 1991; Scheiner et al., 1994; Van Toi & Riva, 1995; but the mechanisms involved in retinal neuro-vascular response are not entirely clear.
We have recently introduced a method which allows for online measurement of retinal vessel diameters during flicker stimulation based on a commercially available retinal vessel analyser (RVA). Using this technique retinal vasodilation in response to diffuse luminance flickering light can be investigated with high reproducibility. This allows for investigations into the mechanisms underlying retinal vasodilation and for interventions which may possibly alter the response. In the present study the vessel response to flickering light was investigated during different levels of hyperglycemia in a group of healthy young subjects. This was done in an effort to gain more insight into retinal blood flow dysregulation in diabetes (Bursell et al., 1996; Schmetterer & Wolzt, 1999) .
Methods
After approval of the study protocol by the Ethics Committee of the Vienna University School of Medicine and after written informed consent was obtained, 12 healthy, non-smoking (nicotine absence P 5 years), drug-free male volunteers between 23 and 29 years of age (mean AE SD: 25.0 AE 2.1 years) were enrolled in the study.
A screening examination was passed by all subjects including medical history, a physical examination, 12-lead electrocardiogram, complete blood tests, an oral glucose tolerance test, urine analysis, and an urine drugscreening. An ophthalmic examination had to be normal in all subjects. Ametropia of less than 3 diopters, and anisometropia of less than 1 diopter was a prerequisite.
Subjects were asked to refrain from alcohol and caffeine for at least 12 h before the study day. The study was performed after an overnight fast in a quiet room with an ambient temperature of 22°C that had complete resuscitation facilities. Baseline systemic hemodynamics were reached within 30 min, which was verified by repeated blood pressure monitoring.
Study design
The study was performed on two separate study days in a two way cross over design. The person evaluating the recordings of the RVA and the participating subjects were masked regarding intravenous treatments. On one study day a hyperglycemic insulin clamp according to De Fronzo, Tobin, and Andress (1997) was performed. During this hyperglycemic insulin clamp endogenous insulin production is blocked by a continuous somatostatin infusion (Somatostatin UBC Pharma, Vienna, Austria; 0.1 lg/kg/min for 210 min, dose reference: Roden et al. (1996) ), and insulin (Huminsulin ''Lilly'', Eli Lilly, Vienna, Austria) is co-infused at 0.1 mU/kg/ min to substitute basal insulin. With this technique blood glucose can be increased to predefined levels at physiological insulin plasma levels. This is important, because in healthy humans both insulin and glucose increase ocular blood flow (Luksch et al., 2001) . In the present study the glucose plasma level was set to 100, 200 and 300 mg/dl by adapting the infusion rate of a 20% glucose infusion (Glucose 20% ''Mayrhofer'', Mayrhofer Pharmaceuticals, Linz, Austria). Each glucose level was calibrated within 30 min and kept for the following 30 min. On the other study day a comparable amount of physiologic saline solutions was infused to guarantee masked conditions.
Zeiss retinal vessel analyser
The Zeiss RVA is a commercially available system which comprises a fundus camera (Zeiss FF 450, Jena, Germany), a video camera, a real time monitor and a personal computer with an analyzing software for accurate determination of retinal arterial and venous vessel diameters (Vilser et al., 1997) . Retinal vessel diameters are analysed in real time at 50 Hz, obtaining 25 vessel diameter readings per second. The fundus image is recorded by a video camera, digitised using a frame grabber and displayed on a real time monitor. Simultaneously, the signal is stored on a video tape, allowing off-line re-analyses of different vessel diameters.
Each blood vessel has a specific transmittance profile due to the absorbing properties of hemoglobin. The software of the RVA calculates retinal vessel diameters with adaptive algorithms using these specific profiles. Whenever a specific vessel profile is recognised the RVA is able to follow this vessel as long as it appears within the measurement window. This means that the system is able to automatically correct for alterations in luminance as induced for instance by slight eye movements. If the requirements for the assessment of retinal vessel diameters are not fulfilled anymore, as it occurs during blinks, the system automatically stops the measurement of vessel diameter. As soon as an adequate fundus image is achieved again, measurement of vessel diameters restarts automatically.
To select a region of interest the user defines a rectangle on the screen of the real time monitor. This window can either include a retinal artery or a retinal vein or both. Thereafter the measurement of vessel diameters can be started. Retinal vessel diameter is then calculated along the arterial or venous segment, which lies within the rectangle.
Measurement of blood glucose
Blood glucose was measured every 5-10 min from arterialized venous blood samples using a Beckman glucose analyser (Beckman Coulter, Inc. Fullerton, CA, USA). For this purpose the contralateral arm, which was not used for intravenous drug administration was placed in a heating box.
Flicker stimulus with a Grass
â PS-2 photo stimulation model Before drug infusion and at the end of each infusion period retinal vessel diameters were continuously measured for 352 s. Diffuse luminance flickering light was applied consecutively for 16, 32 and 64 s at a frequency of 8 Hz during measurements with the RVA. Before and after each flicker period 60 s of baseline recordings were scheduled ( Fig. 1) . In order to avoid that the flickering light interferes with the fundus recordings using the Zeiss RVA the light of the fundus camera and the light used for flicker stimulation had to be separated. A wavelength separation technique was used for this purpose: One interference filter with a centre wavelength of 590 nm and a bandwidth of 10 nm was introduced in the illumination pathway of the fundus camera. Hence, the eye was illuminated with light containing wavelengths between 580 and 600 nm. In this wavelength range the contrast between blood vessels and the surrounding tissue is optimal. A matching interference filter was placed in front of the video camera used for fundus recordings. This ensures that only light consisting of the wavelength used for illumination is seen by the video camera.
For flicker stimulation white light in combination with a 550 nm low pass cut-off filter was used. This ensures that light with a wavelength below 550 nm is used for stimulation. This light was directly coupled to the illumination pathway of the fundus camera. Hence, the light used for flicker stimulation does not pass to the video camera but is perceived by the subject under study. This ensures constant illumination at the fundus image, a prerequisite for adequate vessel diameter measurement. The flicker was centred in the macula with an angle of approximately 30°. All measured vessel segments were within 1-2 disc diameters from the margin of the optic disc and within the area illuminated with flickering light. The illumination light of the fundus camera was kept at the lowest possible intensity in order to increase the contrast to the flickering light. This was achieved by a retinal irradiance of approximately 220 lW/cm 2 . The flash intensity was set to 16 on the control unti of the Grass PS-2 photo stimulator. The coefficient of variation of the flicker responses is less than 25% (Polak, Schmetterer, & Riva, 2002) .
Data analysis
The mean retinal vessel diameter as averaged from 10 s preceding the start of the flicker stimulation was defined as the baseline diameter. These values were taken to assess the effect of blood glucose on retinal vessel diameters as well as to calculate the response to flicker stimulation. The flicker response was defined as the difference between the last 10 s of the flicker period and the pre-flicker vessel diameter, and was expressed as % change from baseline.
For data description results are presented as means AE SEM. The effect of glucose and flickering light on the outcome variables was assessed with a repeated measure ANOVA model. Effects of flicker stimulation on retinal vessel diameters were tested versus the pre-flicker values. Effects of hyperglycemia on the outcome parameters were tested versus placebo. A two tailed p ¼ 0:05 was considered the level of significance.
Results
The insulin clamp was well tolerated by all 12 subjects. Systemic hemodynamics remained constant throughout both study days (Table 1) . Baseline vessel diameters are presented in Table 1 . The increase in blood glucose had no consistent effect on retinal arterial and venous vessel diameter. On the clamp day mean blood glucose plasma levels immediately before RVA measurements were 100 AE 2 mg/dl (mean AE SEM, at step 1), 210 AE 4 mg/dl (step 2) and 306 AE 2 mg/dl (step 3), respectively.
A sample measurement of a retinal venous diameter during flickering light stimulation is presented in Fig. 1 . On the placebo day stimulation with flickering light increased retinal venous and arterial diameters between 1.8% and 2.7% versus baseline (p < 0:0001; ANOVA, Table 2 ). The flicker response was comparable with 16, 32 and 64 s of stimulation. Placebo had no significant effect on flicker responses in retinal arteries or veins.
On the clamp study day flicker stimulation increased venous vessel diameters at 100 mg/dl blood glucose by +2.0 AE 0.4%, +2.5 AE 0.6% and +2.6 AE 0.4% and arterial vessel diameters by +2.7 AE 0.4%, +2.9 AE 0.6% and +2.8 AE 0.4% during 16, 32 and 64 s of flicker stimulation, respectively. These flicker responses were comparable to those seen on the placebo day.
In retinal arteries hyperglycemia at plasma glucose levels of 200 and 300 mg/dl did not significantly change the response of retinal vessel diameters during flickering light stimulation. A tendency towards reduced flicker responses in arteries was, however, seen. At 300 mg/dl the increase in retinal arterial diameters was 21% (16 s of flicker), 30% (32 s of flicker) and 6% (64 s of flicker) smaller than at plasma glucose levels of 100 mg/dl (p ¼ ns; ANOVA; Table 3 ).
In retinal veins the increase in blood glucose to 200 mg/dl had no significant effect on the increase of diameters during flicker stimulation. In contrast, 300 mg/dl significantly decreased the flicker response in retinal veins by 55% (16 s of flicker, p ¼ 0:015 versus 100 mg/dl, ANOVA), by 51% (32 s of flicker, p ¼ 0:015 versus 100 mg/dl, ANOVA) and by 37% (64 s of flicker, p ¼ 0:023; ANOVA versus 100 mg/dl) at the three flicker periods, respectively.
Discussion
We present a method which allows for real time measurement of retinal vessel diameters during flicker stimulation in humans. Using this novel approach the data of the present study indicate that hyperglycemia reduces flicker-induced vasodilation in human retinal branch veins.
There is now convincing evidence that the increase in retinal and optic nerve blood flow in response to flicker stimulation is a direct consequence of retinal neural activity. On the one hand the increase in optic nerve head blood flow shows similar characteristics as com- ANOVA describes significance between control (placebo) and clamp study day. Table 2 Control day: % increase of retinal vessel diameters during flickering light stimulation (n ¼ 12)
Placebo infusions
Step 1 Step 2 Step 3 Means AE SEM were calculated from the last 10 s of each flicker stimulation period.
pared to ganglion cell spiking when plotted as a function of flicker-frequency, modulation depth and relative chromaticity (Riva, Falsini, & Logean, 2001 ). On the other hand the response in optic nerve head blood flow during flicker stimulation is similar and directly correlated to the first and second harmonic amplitudes of the flicker electroretinogram (Falsini, Riva, & Logean, 2002) . Whereas these results show that retinal and optic nerve head blood flow changes in response to flickering light stimulation are a consequence of retinal neural activity (Falsini et al., 2002) , the mechanisms underlying vasodilation are unclear.
Previous animal studies have shown that flicker stimulation alters retinal glucose metabolism. have revealed that in the cat up to 80% of the glucose is metabolised in the retina by aerobic lactate production. The same group has shown that in rabbits retinal glucose consumption and lactate formation increases by approximately 15-20% during flicker stimulation (Wang, Kondo, & Bill, 1997 ). This appears to be related to the changes in ocular perfusion, because plasma lactate and plasma pyruvate modulate flickerinduced retinal blood flow changes in the rat (Ido, Chang, Woolsey, & Williamson, 2001) .
To finally answer the question how hyperglycemia and flicker-induced vasodilation interact data from the retinal microvasculature are required, but there is a lack of methods for real time assessment of human retinal microvessels in vivo. This problem also applies for the Zeiss RVA and vessels which have a diameter below 20 lm and contribute most to vascular resistance, cannot be measured due to the limited resolution of the technique. In principle such information may also be gained from measurements of retinal blood velocity using bidirectional laser Doppler velocimetry allowing for calculation of total retinal blood flow (Riva, Grunwald, Sinclair, & Petrig, 1985) . However, to obtain reproducible flicker responses with this system is difficult, because excellent target fixation is required. Interestingly, hyperglycemia at 300 mg/dl plasma glucose reduced the flicker response in veins but not in arteries. This may either be related to differences in the mechanism underlying flicker-induced vasodilation or more likely indicates interaction between the flicker response and hyperglycemia at the level of the retinal microvasculature.
Our study is, however, well compatible with numerous previous reports indicating vasoactive properties of glucose in the eye and retinal vascular dysregulation in diabetes. Various animal (Atherton, Hill, Keen, Young, & Edwards, 1980; Ernest, Goldstick, & Engerman, 1983; Sullivan, Davies, Caldwell, Morris, & Kohner, 1990 ) and human studies (Luksch et al., 2001 ) have shown that glucose increases ocular blood flow. Sullivan et al. (1990) revealed that hyperglycemia increases retinal blood flow by increasing retinal blood velocity without affecting retinal branch vein diameters. This is in keeping with the results of the present study where no effect on basal retinal arterial and venous diameters was seen at plasma glucose concentrations of 300 mg/dl. Retinal perfusion abnormalities in patients with diabetes are complex and largely depend on the stage of diabetic retinopathy. There is, however, evidence that early stages of diabetic retinopathy are associated with increased retinal blood flow and retinal vasodilation (Falck & Laatikainen, 1995; Grunwald, Du Pont, & Riva, 1996; Grunwald, Riva, Sinclair, Brucker, & Petrig, 1986; Patel, Rassam, Newsom, Wiek, & Kohner, 1992) associated with an abnormal retinal vascular response to hyperoxia (Grunwald, Riva, Petrig, Sinclair, & Brucker, 1984; Patel, Rassam, Chen, & Kohner, 1994) and abnormal retinal autoregulation (Rassam, Patel, & Kohner, 1995; Sinclair et al., 1982) .
One potential limitation of the present study is that hyperglycemia reduced neuronal activity during flicker stimulation rather than affecting neuro-vascular coupling. This is, however, unlikely because there is no evidence that acute hyperglycemia affects visual evoked potentials in patients with type I diabetes (Martinelli et al., 1992) .
In conclusion, the modified RVA as employed in the present study is capable of studying flicker responses in retinal arteries and veins. The reproducibility of this response to flicker stimulation is adequate to study potential mechanisms underlying this effect. Using this technique, we have shown that hyperglycemia reduces the response of retinal veins to flicker stimulation. The relevance of this finding for diabetes associated eye disease remains to be shown.
